STOCK TITAN

Cibus, Inc. - $CBUS STOCK NEWS

Welcome to our dedicated page for Cibus news (Ticker: $CBUS), a resource for investors and traders seeking the latest updates and insights on Cibus stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cibus's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cibus's position in the market.

Rhea-AI Summary
Cibus, Inc. (Nasdaq: CBUS) will report its first quarter 2024 financial results on May 9, 2024. The company, a leader in agricultural biotechnology using gene editing technologies for plant traits, will host a conference call to discuss the results and company updates. Participants can join the call or access a replay via phone or online.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
conferences earnings
-
Rhea-AI Summary
Cibus, Inc. (CBUS) achieved significant milestones in 2023, including successful transfers of gene-edited elite germplasm for commercialization, collaboration agreements with major seed companies, positive greenhouse and field trial results, and opening a gene editing production facility. The company also reported a positive vote in the EU Parliament for new genomic techniques, a breakthrough in regenerating Wheat plants, and raised $20.3 million via a direct offering. The CEO highlighted the progress in commercializing developed traits, advancements in Sclerotinia resistance, and the industry's shift towards gene editing technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.1%
Tags
-
Rhea-AI Summary
Cibus, Inc. (Nasdaq: CBUS) has been recognized as the 2nd most innovative company in the agriculture category on Fast Company's list of the World's Most Innovative Companies of 2024. The company uses gene editing technologies to develop plant traits, aiming to transform the agricultural industry. Cibus has achieved significant milestones, including merging with Calyxt, opening a cutting-edge facility, and successfully commercializing traits like Pod Shatter Reduction in Canola and herbicide tolerance traits in Rice. The company's proprietary gene editing platform, RTDS, is driving its vision of creating sustainable food solutions and reducing chemical use in agriculture.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.8%
Tags
none
Rhea-AI Summary
Cibus, Inc. (CBUS) announced participation in the 36th Annual Roth Conference to discuss gene editing in agriculture and the implications of a post-GMO era.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.67%
Tags
conferences
-
Rhea-AI Summary
Cibus, Inc. (CBUS) will report its fourth quarter 2023 financial results on March 21, 2024. The management team will host a conference call and webcast to discuss the results and company updates.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.16%
Tags
conferences earnings
-
Rhea-AI Summary
Cibus, Inc. (CBUS) collaborates with Loveland Products to develop herbicide tolerance traits in rice, targeting the southern US market. The partnership aims to address weed management challenges for rice growers, leveraging Cibus' Trait MachineTM technology for accelerated trait development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
none
Rhea-AI Summary
The European Parliament has voted in favor of a new regulation for plants obtained by certain new genomic techniques, aiming to increase the sustainability and resilience of the EU food system. Cibus, Inc. (Nasdaq: CBUS) welcomes the vote and applauds the EU Parliament for supporting a science-based approach. The legislation will facilitate international trade and benefit EU growers by bringing EU policy closer to that of trading partners in North and South America, UK, India, Australia, and Japan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.54%
Tags
none
-
Rhea-AI Summary
The Environment Committee of the European Parliament has voted in favor of a new regulation on plants obtained by certain new genomic techniques (NGTs) and their food and feed, with the legislation moving to a plenary session of the European Parliament. Cibus, Inc. (Nasdaq: CBUS) welcomes the vote and the proposed regulation, which identifies a 'Conventional-like' category of NGT products that would be regulated as conventional varieties, bringing EU policy closer to that of trading partners in other countries. The legislation aims to ensure resilient and sustainable use of the EU's natural resources and has received support from Nobel Laureates and scientists for fostering innovation, enhancing food security, and boosting climate resilience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Summary
Cibus, Inc. (NASDAQ: CBUS) has announced successful field trials for its rice herbicide tolerance traits, HT1 and HT3, and its canola Pod Shatter Reduction (PSR) trait. The company is preparing for the commercial launch of these traits, with field scale demonstrations in the US Mid-South and plans to integrate the traits into product lines. Cibus also reported that its PSR trait in canola seed developer genetics performed well, leading to the first hybrid sales as early as 2025. The company aims to change the canola/WOSR market by broadly licensing its PSR trait to seed developers globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.22%
Tags
none
Rhea-AI Summary
Cibus, Inc. (NASDAQ: CBUS) successfully regenerates plants from single cells in a wheat cultivar, representing a major breakthrough for the company and the seed industry. This achievement accelerates trait development in wheat, a key crop for global food security, and demonstrates Cibus' success in developing scalable high throughput breeding platforms for major crops.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.27%
Tags
none
Cibus, Inc.

Nasdaq:CBUS

CBUS Rankings

CBUS Stock Data

368.88M
16.54M
17.74%
26.94%
1.8%
All Other Grain Farming
Agriculture, Forestry, Fishing and Hunting
Link
United States of America
SAN DIEGO